US approves oral drug for adults with rare type of lung cancer after early clinical trials globally

Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at straitstimes.com. Read more at straitstimes.com.

Former Virginia Beach Navy SEAL touts healing benefits of psychedelics in new Netflix documentary

After 17 years of service to his country filled with physical and mental strain, a retired Navy SEAL was contemplating ...